The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479328/805-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479328/805-10-50-2

Name:	us-gaap_BusinessAcquisitionsProFormaRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Acquisitions, Revenue and Pro Forma Revenue (Details) - LifeDNA and BeautyBio [Member] - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Acquisitions [Abstract]
Unaudited pro forma revenue as if acquisitions occurred on January 1, 2022	$ 504.1	$ 564.9	$ 990.0	$ 1,175.0
Rhyz Other [Member]
Acquisitions [Abstract]
Revenue since acquisitions	$ 0.9